2012 annual financial data
Abeona Therapeutics 2012 Operating margin
Direct answer
Operating margin was -98%.
Operating income was -4,316,000 USD and net income was -10,532,000 USD.
Operating cash flow was -3,955,000 USD.
Get free Abeona Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,404,000 USD
- Operating income
- -4,316,000 USD
- Net income
- -10,532,000 USD
- Operating cash flow
- -3,955,000 USD